查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1504923

誘導性多能幹細胞（iPSC）市場、佔有率、規模、趨勢、行業分析報告：按衍生細胞、按工作流程、依應用、依地區、依細分市場、預測，2024-2032年

Induced Pluripotent Stem Cell Market Share, Size, Trends, Industry Analysis Report, By Derived Cell; By Workflow; By Application; By Region; Segment Forecast, 2024 - 2032
出版日期: | 出版商: Polaris Market Research | 英文 118 Pages | 商品交期: 最快1-2個工作天內

價格

根據Polaris Market Research的最新研究，到2032年，全球誘導多能幹細胞（iPSC）市場預計將達到43.5556億美元。本研究報告提供了對當前市場動態的詳細洞察，並對未來市場成長進行了分析。

老年人口的增加、慢性病的增加以及研發的進步促進 iPSC 市場的不斷擴大。這種成長吸引了世界各地對先進藥物開發和測試感興趣的製藥公司的大量投資，促進了 iPSC 市場的整體成長。

雖然整個幹細胞工作流程很複雜，但它為新手提供了獨特的 iPSC 製造機會。 iPSC 生產包括的關鍵而複雜的過程，包括生成、重編程和分化成各種所需的細胞類型，都需要專業知識和資源。然而，透過購買市售 iPSC 衍生細胞和外包編程的選擇，鼓勵新進業者探索該領域並為其發展做出貢獻。

進入市場有多種選擇：致力於內部重編程和分化、從商業產品組合中購買 iPSC 衍生細胞類型，或與第三方提供者簽訂合約。客製化模型。這一趨勢激發了使用基於 iPSC 的模型進行許多疾病模型、表型測定和毒理學測試的潛力。

生物製藥是從微生物中提取的藥物，例如荷爾蒙、疫苗、單株抗體、治療酵素和血液因子。這些藥物具有高度特異性，為醫療保健開闢新途徑，包括個人化醫療。這種方法根據患者的生理、生物和遺傳組成，使用特定的生物分子來治療各種疾病和病症。傳統製藥的有限範圍和生物技術行業參與者的缺乏刺激細胞培養技術的發展。

iPSC 市場報告亮點

2023年，全球市場出現顯著成長，心肌細胞成為主導細分市場。這是因為心肌細胞（負責心臟收縮和泵血作用的心臟特殊肌肉細胞）因其潛在的治療應用而受到廣泛關注。

預計再生醫學產業在未來幾年將經歷顯著的成長。再生醫學包括針對組織和器官的修復、替換和再生的治療技術，以恢復遭受損傷或疾病的個體的正常功能。

北美地區憑藉著在生物醫學領域的廣泛研究和創新在全球市場佔據主導地位。

目錄

第1章 簡介

第2章 執行摘要

第3章 研究方法

第4章 全球誘導性多能幹細胞（iPSC）市場洞察

  • 工作流程快照
  • 誘導性多能幹細胞（iPSC）市場動態
    • 推動因素和機會
      • 身體重建手術和組織工程的需求不斷增加
      • 對疫苗生產、人造器官、培養基和生物製藥的需求不斷增加
    • 抑制因素和挑戰
      • 有關動物的道德問題
  • PESTEL 分析
  • 誘導多能幹細胞（iPSC）市場的工作流程趨勢
  • 價值鏈分析
  • 新冠肺炎（COVID-19）影響分析

第5章 全球誘導性多能幹細胞（iPSC）市場：依衍生性細胞類型劃分

  • 主要發現
  • 簡介
  • 肝細胞
  • 纖維母細胞
  • 神經細胞
  • 羊膜細胞
  • 心肌細胞
  • 其他

第6章 全球誘導多能幹細胞（iPSC）市場：依應用劃分

  • 主要發現
  • 簡介
  • 製造業
  • 學術研究
  • 藥物開發與發現
  • 毒性篩檢
  • 再生醫學

第7章 全球誘導性多能幹細胞（iPSC）市場：依工作流程

  • 主要發現
  • 簡介
  • 重新編程
  • 細胞培養
  • 細胞表徵/分析
  • 工程
  • 其他

第8章 全球誘導性多能幹細胞（iPSC）市場：依地區

  • 主要發現
  • 簡介
    • 誘導多能幹細胞（iPSC）市場評估：地區，2019-2032年
  • 北美
    • 北美：依衍生細胞劃分，2019-2032年
    • 北美：依工作流程劃分，2019-2032年
    • 北美：依用途劃分，2019-2032年
    • 美國
    • 加拿大
  • 歐洲
    • 歐洲：依衍生細胞劃分，2019-2032年
    • 歐洲：依工作流程劃分，2019-2032年
    • 歐洲：依用途劃分，2019-2032年
    • 英國
    • 法國
    • 德國
    • 義大利
    • 西班牙
    • 荷蘭
    • 俄羅斯
  • 亞太地區
    • 亞太地區：依衍生細胞劃分，2019-2032年
    • 亞太地區：依工作流程劃分，2019-2032年
    • 亞太地區：依應用程式劃分，2019-2032年
    • 中國
    • 印度
    • 馬來西亞
    • 日本
    • 印尼
    • 韓國
  • 中東、非洲
    • 中東與非洲：依衍生格劃分，2019-2032年
    • 中東和非洲：依工作流程劃分，2019-2032年
    • 中東與非洲：依用途劃分，2019-2032年
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 南非
  • 拉丁美洲
    • 拉丁美洲：依衍生細胞劃分，2019-2032年
    • 拉丁美洲：依工作流程劃分，2019-2032年
    • 拉丁美洲：依用途劃分，2019-2032年
    • 墨西哥
    • 巴西
    • 阿根廷

第9章 競爭態勢

  • 擴張與收購分析
    • 擴張
    • 收購
  • 夥伴關係/協作/協議/揭露

第10章 公司簡介

  • Astellas Pharma Inc
  • Axol Bioscience Ltd
  • Cynata Therapeutics Limited
  • Fate Therapeutics
  • FUJIFILM Holdings Corporation（Cellular Dynamics）
  • Ncardia
  • REPROCELL Inc.
  • Takara Bio Inc.
  • Thermo Fisher Scientific Inc.
  • ViaCyte, Inc
Product Code: PM2014

The global Induced Pluripotent Stem Cell (iPSC) market size is expected to reach USD 4,355.56 Million by 2032, according to a new study by Polaris Market Research. The report "iPSC Market Share, Size, Trends, Industry Analysis Report, By Derived Cell (Hepatocytes, Fibroblasts, Neural Cells, Amniotic Cells, Cardiomyocytes, Others); By Workflow; By Application; By Region; Segment Forecast, 2024 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The growing elderly population, rising cases of chronic diseases, and advancements in research and development are contributing to the increasing growth of the iPSC market. This growth is attracting significant investments from pharmaceutical companies worldwide, who are interested in advanced drug development and testing, and is thereby catering to the overall growth of the iPSC market.

The overall stem cell workflow, although complex, presents a unique opportunity for new entrants in the production of iPSC. Some of the critical and complex processes involved in the production of iPSC include generation, reprogramming, and differentiation into various desired cell types, which require both expertise and resources. However, with the option of commercial iPSC-derived cell purchase or outsourcing programming, new entrants are encouraged to explore this field and contribute to its growth.

With several market entry options available, several trends are observed, such as concentrated efforts on reprogramming and in-house differentiation, purchase of iPSC-derived cell types from off-the-shelf product portfolios, or entering into agreements with third-party purveyors to produce customized models. This trend has spurred a range of possibilities that will feature iPSC-based models for a host of disease models, phenotypic assays, and toxicology testing.

Biopharmaceuticals are drugs that are derived from microbiological sources such as hormones, vaccines, monoclonal antibodies, therapeutic enzymes, blood factors, and so on. These drugs are highly specific and have opened up new avenues in healthcare, such as personalized medicine. This approach involves treating various diseases or conditions using specific biomolecules depending on the patient's physiological, biological, and genetic makeup. As conventional pharmaceuticals have limited applicability and there are few players in the biotechnology industry, the growth of cell culture technology has been fueled.

iPSC Market Report Highlights

In 2023, the global market witnessed significant growth, with cardiomyocytes emerging as the dominant segment. This is because cardiomyocytes, specialized muscle cells in the heart responsible for its contraction and pumping action, have gained significant attention due to their potential for therapeutic applications.

The regenerative medicine industry is projected to experience a substantial growth rate in the upcoming years. Regenerative medicine involves therapeutic techniques that target the repair, replacement, or regeneration of tissues or organs in order to restore normal function in individuals who are suffering from injury or disease.

The North American region dominated the global market, owing to its extensive research and innovation in the field of biomedical science.

The global key market players include Astellas Pharma Inc., Axol Bioscience Ltd., Cynata Therapeutics Limited, Fate Therapeutics, FUJIFILM Holdings Corporation (Cellular Dynamics), Ncardia, REPROCELL Inc., Takara Bio Inc., Thermo Fisher Scientific Inc., ViaCyte, Inc, etc.

Polaris Market Research has segmented the iPSC market report based on derived cell, workflow, application, and region:

iPSC, Derived Cell Outlook (Revenue - USD Million, 2019 - 2032)

  • Hepatocytes
  • Fibroblasts
  • Neural Cells
  • Excitatory Neurons
  • Inhibitory Neurons
  • Amniotic Cells
  • Cardiomyocytes
  • Others

iPSC, Workflow Outlook (Revenue - USD Million, 2019 - 2032)

  • Reprogramming
  • Cell Culture
  • Cell Characterization / Analysis
  • Engineering
  • Others

iPSC, Application Outlook (Revenue - USD Million, 2019 - 2032)

  • Manufacturing
  • Academic Research
  • Drug Development & Discovery
  • Toxicity Screening
  • Regenerative Medicine

iPSC, Regional Outlook (Revenue - USD Million, 2019 - 2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Austria
  • Netherlands
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Australia
  • Rest of APAC
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Rest of Latin America
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa
  • Rest of MEA

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Induced Pluripotent Stem Cell (iPSC) Market Insights

  • 4.1. Induced Pluripotent Stem Cell (iPSC) Market - Workflow Snapshot
  • 4.2. Induced Pluripotent Stem Cell (iPSC) Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Increasing demand for body reconstruction procedures and tissue engineering
      • 4.2.1.2. Rising Demand for Vaccine Production, Artificial Organs, Media, and Biopharmaceuticals
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1 Ethical Concerns Pertaining to Animals
    • 4.2.3 Porter's Five Forces Analysis
      • 4.2.3.1. Bargaining Power of Suppliers (Moderate)
      • 4.2.3.2. Threats of New Entrants: (Low)
      • 4.2.3.3. Bargaining Power of Buyers (Moderate)
      • 4.2.3.4. Threat of Substitute (Moderate)
      • 4.2.3.5 Rivalry among existing firms (High)
  • 4.3. PESTEL Analysis
  • 4.4. Induced Pluripotent Stem Cell (iPSC) Market Workflow Trends
  • 4.5. Value Chain Analysis
  • 4.6. COVID-19 Impact Analysis

5. Global Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
  • 5.3. Hepatocytes
    • 5.3.1. Global Induced Pluripotent Stem Cell (iPSC) Market, by Hepatocytes, by Region, 2019-2032 (USD Million)
  • 5.4. Fibroblasts
    • 5.4.1. Global Induced Pluripotent Stem Cell (iPSC) Market, by Fibroblasts, by Region, 2019-2032 (USD Million)
  • 5.5. Neural Cells
    • 5.5.1. Global Induced Pluripotent Stem Cell (iPSC) Market, by Neural Cells, by Region, 2019-2032 (USD Million)
    • 5.5.2. Excitatory Neurons
      • 5.5.2.1. Global Induced Pluripotent Stem Cell (iPSC) Market, by Excitatory Neurons, by Region, 2019-2032 (USD Million)
    • 5.5.3. Inhibitory Neurons
      • 5.5.3.1. Global Induced Pluripotent Stem Cell (iPSC) Market, by Inhibitory Neurons, by Region, 2019-2032 (USD Million)
  • 5.6. Amniotic Cells
    • 5.6.1. Global Induced Pluripotent Stem Cell (iPSC) Market, by Amniotic Cells, by Region, 2019-2032 (USD Million)
  • 5.7. Cardiomyocytes
    • 5.7.1. Global Induced Pluripotent Stem Cell (iPSC) Market, by Cardiomyocytes, by Region, 2019-2032 (USD Million)
  • 5.8. Others
    • 5.8.1. Global Induced Pluripotent Stem Cell (iPSC) Market, by Others, by Region, 2019-2032 (USD Million)

6. Global Induced Pluripotent Stem Cell (iPSC) Market, by Application

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
  • 6.3. Manufacturing
    • 6.3.1. Global Induced Pluripotent Stem Cell (iPSC) Market, by Manufacturing, by Region, 2019-2032 (USD Million)
  • 6.4. Academic Research
    • 6.4.1. Global Induced Pluripotent Stem Cell (iPSC) Market, by Academic Research, by Region, 2019-2032 (USD Million)
  • 6.5. Drug Development & Discovery
    • 6.5.1. Global Induced Pluripotent Stem Cell (iPSC) Market, by Drug Development & Discovery, by Region, 2019-2032 (USD Million)
  • 6.6. Toxicity Screening
    • 6.6.1. Global Induced Pluripotent Stem Cell (iPSC) Market, by Toxicity Screening, by Region, 2019-2032 (USD Million)
  • 6.7. Regenerative Medicine
    • 6.7.1. Global Induced Pluripotent Stem Cell (iPSC) Market, by Regenerative Medicine, by Region, 2019-2032 (USD Million)

7. Global Induced Pluripotent Stem Cell (iPSC) Market, by Workflow

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
  • 7.3. Reprogramming
    • 7.3.1. Global Induced Pluripotent Stem Cell (iPSC) Market, by Reprogramming, By Region, 2019-2032 (USD Million)
  • 7.4. Cell Culture
    • 7.4.1. Global Induced Pluripotent Stem Cell (iPSC) Market, by Cell Culture, By Region, 2019-2032 (USD Million)
  • 7.5. Cell Characterization / Analysis
    • 7.5.1. Global Induced Pluripotent Stem Cell (iPSC) Market, by Cell Characterization / Analysis, By Region, 2019-2032 (USD Million)
  • 7.6. Engineering
    • 7.6.1. Global Induced Pluripotent Stem Cell (iPSC) Market, by Engineering, By Region, 2019-2032 (USD Million)
  • 7.7. Others
    • 7.7.1. Global Induced Pluripotent Stem Cell (iPSC) Market, by Others, By Region, 2019-2032 (USD Million)

8. Global Induced Pluripotent Stem Cell (iPSC) Market, by Geography

  • 8.1. Key findings
  • 8.2. Introduction
    • 8.2.1. Induced Pluripotent Stem Cell (iPSC) Market Assessment, By Geography, 2019-2032 (USD Million)
  • 8.3. Induced Pluripotent Stem Cell (iPSC) Market - North America
    • 8.3.1. North America: Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
    • 8.3.2. North America: Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
    • 8.3.3. North America: Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
    • 8.3.4. Induced Pluripotent Stem Cell (iPSC) Market - U.S.
      • 8.3.4.1. U.S.: Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
      • 8.3.4.2. U.S.: Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
      • 8.3.4.3. U.S.: Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
    • 8.3.5. Induced Pluripotent Stem Cell (iPSC) Market - Canada
      • 8.3.5.1. Canada: Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
      • 8.3.5.2. Canada.: Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
      • 8.3.5.3. Canada: Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
  • 8.4. Induced Pluripotent Stem Cell (iPSC) Market - Europe
    • 8.4.1. Europe: Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
    • 8.4.2. Europe.: Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
    • 8.4.3. Europe: Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
    • 8.4.4. Induced Pluripotent Stem Cell (iPSC) Market - UK
      • 8.4.4.1. UK: Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
      • 8.4.4.2. UK.: Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
      • 8.4.4.3. UK: Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
    • 8.4.5. Induced Pluripotent Stem Cell (iPSC) Market - France
      • 8.4.5.1. France: Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
      • 8.4.5.2. France.: Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
      • 8.4.5.3. France: Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
    • 8.4.6. Induced Pluripotent Stem Cell (iPSC) Market - Germany
      • 8.4.6.1. Germany: Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
      • 8.4.6.2. Germany.: Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
      • 8.4.6.3. Germany: Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
    • 8.4.7. Induced Pluripotent Stem Cell (iPSC) Market - Italy
      • 8.4.7.1. Italy: Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
      • 8.4.7.2. Italy.: Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
      • 8.4.7.3. Italy: Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
    • 8.4.8. Induced Pluripotent Stem Cell (iPSC) Market - Spain
      • 8.4.8.1. Spain: Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
      • 8.4.8.2. Spain.: Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
      • 8.4.8.3. Spain: Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
    • 8.4.9. Induced Pluripotent Stem Cell (iPSC) Market - Netherlands
      • 8.4.9.1. Netherlands: Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
      • 8.4.9.2. Netherlands.: Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
      • 8.4.9.3. Netherlands: Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
    • 8.4.10. Induced Pluripotent Stem Cell (iPSC) Market - Russia
      • 8.4.10.1. Russia: Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
      • 8.4.10.2. Russia.: Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
      • 8.4.10.3. Russia: Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
  • 8.5. Induced Pluripotent Stem Cell (iPSC) Market - Asia Pacific
    • 8.5.1. Asia Pacific: Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
    • 8.5.2. Asia Pacific.: Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
    • 8.5.3. Asia Pacific: Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
    • 8.5.4. Induced Pluripotent Stem Cell (iPSC) Market - China
      • 8.5.4.1. China: Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
      • 8.5.4.2. China.: Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
      • 8.5.4.3. China: Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
    • 8.5.5. Induced Pluripotent Stem Cell (iPSC) Market - India
      • 8.5.5.1. India: Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
      • 8.5.5.2. India.: Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
      • 8.5.5.3. India: Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
    • 8.5.6. Induced Pluripotent Stem Cell (iPSC) Market - Malaysia
      • 8.5.6.1. Malaysia: Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
      • 8.5.6.2. Malaysia.: Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
      • 8.5.6.3. Malaysia: Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
    • 8.5.7. Induced Pluripotent Stem Cell (iPSC) Market - Japan
      • 8.5.7.1. Japan: Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
      • 8.5.7.2. Japan.: Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
      • 8.5.7.3. Japan: Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
    • 8.5.8. Induced Pluripotent Stem Cell (iPSC) Market - Indonesia
      • 8.5.8.1. Indonesia: Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
      • 8.5.8.2. Indonesia.: Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
      • 8.5.8.3. Indonesia: Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
    • 8.5.9. Induced Pluripotent Stem Cell (iPSC) Market - South Korea
      • 8.5.9.1. South Korea: Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
      • 8.5.9.2. South Korea.: Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
      • 8.5.9.3. South Korea: Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
  • 8.6. Induced Pluripotent Stem Cell (iPSC) Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
    • 8.6.2. Middle East & Africa.: Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
    • 8.6.3. Middle East & Africa: Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
    • 8.6.4. Induced Pluripotent Stem Cell (iPSC) Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
      • 8.6.4.2. Saudi Arabia.: Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
      • 8.6.4.3. Saudi Arabia: Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
    • 8.6.5. Induced Pluripotent Stem Cell (iPSC) Market - UAE
      • 8.6.5.1. UAE: Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
      • 8.6.5.2. UAE.: Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
      • 8.6.5.3. UAE: Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
    • 8.6.6. Induced Pluripotent Stem Cell (iPSC) Market - Israel
      • 8.6.6.1. Israel: Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
      • 8.6.6.2. Israel.: Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
      • 8.6.6.3. Israel: Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
    • 8.6.7. Induced Pluripotent Stem Cell (iPSC) Market - South Africa
      • 8.6.7.1. South Africa: Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
      • 8.6.7.2. South Africa.: Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
      • 8.6.7.3. South Africa: Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
  • 8.7. Induced Pluripotent Stem Cell (iPSC) Market - Latin America
    • 8.7.1. Latin America: Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
    • 8.7.2. Latin America.: Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
    • 8.7.3. Latin America: Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
    • 8.7.4. Induced Pluripotent Stem Cell (iPSC) Market - Mexico
      • 8.7.4.1. Mexico: Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
      • 8.7.4.2. Mexico.: Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
      • 8.7.4.3. Mexico: Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
    • 8.7.5. Induced Pluripotent Stem Cell (iPSC) Market - Brazil
      • 8.7.5.1. Brazil: Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
      • 8.7.5.2. Brazil.: Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
      • 8.7.5.3. Brazil: Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
    • 8.7.6. Induced Pluripotent Stem Cell (iPSC) Market - Argentina
      • 8.7.6.1. Argentina: Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
      • 8.7.6.2. Argentina.: Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
      • 8.7.6.3. Argentina: Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. Astellas Pharma Inc
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product Benchmarking
    • 10.1.4. Recent Development
  • 10.2. Axol Bioscience Ltd
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product Benchmarking
    • 10.2.4. Recent Development
  • 10.3. Cynata Therapeutics Limited
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product Benchmarking
    • 10.3.4. Recent Development
  • 10.4. Fate Therapeutics
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product Benchmarking
    • 10.4.4. Recent Development
  • 10.5. FUJIFILM Holdings Corporation (Cellular Dynamics)
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product Benchmarking
    • 10.5.4. Recent Development
  • 10.6. Ncardia
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product Benchmarking
    • 10.6.4. Recent Development
  • 10.7. REPROCELL Inc.
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Product Benchmarking
    • 10.7.4. Recent Development
  • 10.8. Takara Bio Inc.
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Product Benchmarking
    • 10.8.4. Recent Development
  • 10.9. Thermo Fisher Scientific Inc.
    • 10.9.1. Company Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Product Benchmarking
    • 10.9.4. Recent Development
  • 10.10. ViaCyte, Inc
    • 10.10.1. Company Overview
    • 10.10.2. Financial Performance
    • 10.10.3. Product Benchmarking
    • 10.10.4. Recent Development

List of Tables

  • Table 1 Global Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
  • Table 2 Global Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
  • Table 3 Global Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
  • Table 4 Induced Pluripotent Stem Cell (iPSC) Market Assessment, By Geography, 2019-2032 (USD Million)
  • Table 5 North America: Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
  • Table 6 North America: Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
  • Table 7 North America: Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
  • Table 8 U.S.: Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
  • Table 9 U.S.: Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
  • Table 10 U.S.: Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
  • Table 11 Canada: Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
  • Table 12 Canada: Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
  • Table 13 Canada: Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
  • Table 14 Europe: Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
  • Table 15 Europe: Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
  • Table 16 Europe: Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
  • Table 17 UK: Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
  • Table 18 UK: Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
  • Table 19 UK: Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
  • Table 20 France: Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
  • Table 21 France: Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
  • Table 22 France: Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
  • Table 23 Germany: Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
  • Table 24 Germany: Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
  • Table 25 Germany: Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
  • Table 26 Italy: Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
  • Table 27 Italy: Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
  • Table 28 Italy: Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
  • Table 29 Spain: Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
  • Table 30 Spain: Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
  • Table 31 Spain: Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
  • Table 32 Netherlands: Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
  • Table 33 Netherlands: Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
  • Table 34 Netherlands: Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
  • Table 35 Russia: Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
  • Table 36 Russia: Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
  • Table 37 Russia: Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
  • Table 38 Asia Pacific: Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
  • Table 39 Asia Pacific: Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
  • Table 40 Asia Pacific: Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
  • Table 41 China: Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
  • Table 42 China: Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
  • Table 43 China: Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
  • Table 44 India: Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
  • Table 45 India: Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
  • Table 46 India: Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
  • Table 47 Malaysia: Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
  • Table 48 Malaysia: Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
  • Table 49 Malaysia: Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
  • Table 50 Japan: Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
  • Table 51 Japan: Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
  • Table 52 Japan: Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
  • Table 53 Indonesia: Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
  • Table 54 Indonesia: Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
  • Table 55 Indonesia: Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
  • Table 56 South Korea: Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
  • Table 57 South Korea: Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
  • Table 58 South Korea: Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
  • Table 59 Middle East & Africa: Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
  • Table 60 Middle East & Africa: Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
  • Table 61 Middle East & Africa: Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
  • Table 62 Saudi Arabia: Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
  • Table 63 Saudi Arabia: Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
  • Table 64 Saudi Arabia: Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
  • Table 65 UAE: Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
  • Table 66 UAE: Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
  • Table 67 UAE: Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
  • Table 68 Israel: Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
  • Table 69 Israel: Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
  • Table 70 Israel: Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
  • Table 71 South Africa: Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
  • Table 72 South Africa: Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
  • Table 73 South Africa: Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
  • Table 74 Latin America: Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
  • Table 75 Latin America: Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
  • Table 76 Latin America: Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
  • Table 77 Mexico: Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
  • Table 78 Mexico: Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
  • Table 79 Mexico: Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
  • Table 80 Brazil: Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
  • Table 81 Brazil: Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
  • Table 82 Brazil: Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)
  • Table 83 Argentina: Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2019-2032 (USD Million)
  • Table 84 Argentina: Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2019-2032 (USD Million)
  • Table 85 Argentina: Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2019-2032 (USD Million)

List of Figures

  • Figure 1. Global Induced Pluripotent Stem Cell (iPSC) Market, 2019-2032 (USD Million)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Approach
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Application
  • Figure 7. Global Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2022 & 2032 (USD Million)
  • Figure 8. Market by Derived Cell
  • Figure 9. Global Induced Pluripotent Stem Cell (iPSC) Market, by Derived Cell, 2022 & 2032 (USD Million)
  • Figure 10. Market by Workflow
  • Figure 11. Global Induced Pluripotent Stem Cell (iPSC) Market, by Workflow, 2022 & 2032 (USD Million)
  • Figure 12. Induced Pluripotent Stem Cell (iPSC) Market Assessment, By Geography, 2019-2032 (USD Million)
  • Figure 13. Strategic Analysis - Induced Pluripotent Stem Cell (iPSC) Market